MRVI

MKT CAP:$2B

Maravai Lifesciences Holdings Inc

Market Cap

$2B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$5.04+$1.64 (+48.24%)

Jun 8, 2026

52W High $5.0452W Low $2.01

Company Details

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa...

CEO

—

IPO Date

Nov 20, 2020

Website

www.maravai.com

Key Metrics TTM

Revenue

$205M

-15.4% YoY

Net Income

-$105M

EPS (Diluted)

Free Cash Flow

-$52M

Revenue / Share

$1.40

Gross Margin

29.0%

Operating Margin

21.9%

Net Margin

-51.1%

FCF Margin

-25.3%

P/S

8.6x

P/E

Earnings Reports

Q2 2026

Aug 10, 2026

PENDING

Q1 2026

May 8, 2026

$66M+40.5%

FY 2025

Feb 26, 2026

$186M-28.3%

Q4 2025

Feb 26, 2026

$50M-11.6%

Q3 2025

Nov 7, 2025

$42M-36.2%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee